Key result
In failing human myocardium, the Na+-channel activator (+/-)BDF 9148 and ouabain increased force of contraction as effectively as in nonfailing tissue, with higher potency for (+/-)BDF 9148.
Why the study?
Does (+/-)BDF 9148 or ouabain improve force of contraction in failing human myocardium compared to nonfailing myocardium?
Does (+/-)BDF 9148 or ouabain improve force of contraction in failing human myocardium compared to nonfailing myocardium?
Answers are grounded in this paper and cite their sources.
Agents that increase intracellular Na+ (like BDF 9148 and ouabain) maintain their positive inotropic effectiveness in failing human myocardium, likely due to altered Na+ homeostasis.
AIMS: The aim of the present study was to investigate whether agents which enhance force of contraction via increasing intracellular Na+, i.e. cAMP-independently, remain effective in failing human myocardium. METHODS: Cumulative concentration-response curves with (+/-)BDF 9148 (0.01-10 mumol l-1), a Na(+)-channel activator, and ouabain (0.01-0.1 mumol l-1), a Na+/K(+)-ATPase inhibitor, were performed on electrically driven left ventricular human papillary muscle strips (1 Hz, 37 degrees C; dilative cardiomyopathy, NYHA IV, heart transplantation, n = 16; nonfailing, donor hearts, n = 5). The beta-adrenoceptor agonist isoprenaline (0.001-1 mumol l-1) and Ca2+ (1.8-15 mmol l-1) were studied for control. In addition, Ca2+ response curves were obtained on skinned fibre preparations from left ventricular myocardium (NYHA IV, n = 7) in the presence of BDF 9148 (1 mumol l-1) or a high Na+ concentration (50 mmol l-1) to investigate a possible direct or indirect interaction of (+/-)BDF 9148 with the myofilaments. RESULTS: While isoprenaline was significantly less effective in increasing force of contraction in failing human myocardium than in nonfailing myocardium (P < 0.01), in NYHA IV, (+/-)BDF 9148 and ouabain were as effective as in nonfailing human tissue. In failing and nonfailing myocardium, (+/-)BDF 9148 and ouabain exerted positive inotropic effects similar to those of Ca2+. However, the potency for (+/-)BDF 9148 to increase force of contraction was higher in NYHA IV than in nonfailing human myocardium (P < 0.05). Neither (+/-)BDF 9148 (1 mumol l-1) nor an increased concentration of Na+ (50 mmol l-1) altered the Ca2+ sensitivity or maximal developed tension of the contractile apparatus in experiments on chemically skinned left ventricular fibres. CONCLUSIONS: The enhanced sensitivity of the failing human myocardium towards Na(+)-channel modulation is not due to a direct or indirect interaction of (+/-)BDF 9148 with cardiac myofilaments but may be due to an altered Na(+)-homeostasis in human heart failure.
No takes yet. Share an insight, caveat, or question.
Müller‐Ehmsen et al. (1997) studied Dilative cardiomyopathy, heart failure (n=28). (+/-)BDF 9148 and ouabain vs. Isoprenaline, Ca2+, and nonfailing myocardium was evaluated on Force of contraction (p=<0.05). In failing human myocardium, the Na+-channel activator (+/-)BDF 9148 and ouabain increased force of contraction as effectively as in nonfailing tissue, with higher potency for (+/-)BDF 9148.
Synapse has enriched 10 related papers. Consider them for comparative context: